Vontobel Holding’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Vontobel Holding's XBI Position: Q1 2026 in Review
Vontobel Holding increased its State Street SPDR S&P Biotech ETF (XBI) stake by 134% in Q1 2026, buying an estimated $524K and bringing the position to 7,338 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #674.
Vontobel Holding first reported a position in XBI in Q4 2020 and has held it in 20 quarters since. The position peaked at $3.61M in Q1 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Vontobel Holding held 7,338 shares of State Street SPDR S&P Biotech ETF worth $937K as of Q1 2026.
- Vontobel Holding bought 4,198 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $524K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #674 holding.
- Vontobel Holding first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 20 quarters since.
- Vontobel Holding's State Street SPDR S&P Biotech ETF position peaked at $3.61M in Q1 2023.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.